CA Patent

CA2854380A1 — Methods for treating irritable bowel syndrome (ibs) and infections

Assigned to Salix Pharmaceuticals Inc · Expires 2013-05-10 · 13y expired

What this patent protects

The present invention provides new methods and kits for the retreatment of IBS, for reducing commonly-occurring infections in patients suffering from hepatic encephalopathy, and for reducing frequency of incidence of C. difficile infections.

USPTO Abstract

The present invention provides new methods and kits for the retreatment of IBS, for reducing commonly-occurring infections in patients suffering from hepatic encephalopathy, and for reducing frequency of incidence of C. difficile infections.

Drugs covered by this patent

Patent Metadata

Patent number
CA2854380A1
Jurisdiction
CA
Classification
—
Expires
2013-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Salix Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.